CANCER RESEARCH TECHNOLOGY LIMITED;KOBENHAVNS UNIVERSITET
发明人:
CLAUSEN, HENRIK,BURCHELL, JOY,MANDEL, ULLA,SORENSEN, ANNE LOUISE,TARP, MADS AGERVIG,TAYLOR-PAPADIMITRIOU, JOYCE
申请号：
CA2665356
公开号：
CA2665356C
申请日:
2007.10.04
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention provides a method for inducing a cancer specific immune response against MUC1 using an immunogenic glycopeptide. Other aspects of the invention are a pharmaceutical composition comprising the immunogenic glycopeptide and a cancer vaccine comprising the immunogenic glycopeptide. Another aspect is an antibody generated using the immunogenic glycopeptide and the use of said antibody in therapy and diagnosis.
